Mild to moderate influenza and SARS-CoV-2 infections are associated with prototypical antiviral immune responses involving transient, co-ordinated activation and contraction of virus-specific CD4+ and CD8+ T cells, B cells and antibodies (29–32). The gene discussed is CD4; the disease is influenza.